相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options
Roberta Colucci et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
β-Adrenergic-stimulated macrophages: Comprehensive localization in the M1-M2 spectrum
Donald M. Lamkin et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination
Caroline P. Le et al.
NATURE COMMUNICATIONS (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Clinical Impact of Selective and Nonselective Beta-Blockers on Survival in Patients With Ovarian Cancer
Jack L. Watkins et al.
CANCER (2015)
β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells
Jessica M. Wilson et al.
CANCER BIOLOGY & THERAPY (2015)
β-Blockers Reduce Breast Cancer Recurrence and Breast Cancer Death: A Meta-Analysis
W. Kurtis Childers et al.
CLINICAL BREAST CANCER (2015)
Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials
Maja Thiele et al.
LIVER INTERNATIONAL (2015)
Antiproliferative effects of β-blockers on human colorectal cancer cells
M. Coelho et al.
ONCOLOGY REPORTS (2015)
Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives
Marco Cosentino et al.
Frontiers in Cellular Neuroscience (2015)
Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth
Guillermo N. Armaiz-Pena et al.
ONCOTARGET (2015)
Adrenergic regulation of innate immunity: a review
Angela Scanzano et al.
FRONTIERS IN PHARMACOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression
Maura Calvani et al.
ONCOTARGET (2015)
Fulfilling the Promise of Biased G Protein-Coupled Receptor Agonism
Louis M. Luttrell et al.
MOLECULAR PHARMACOLOGY (2015)
Sympathetic nervous system regulation of the tumour microenvironment
Steven W. Cole et al.
NATURE REVIEWS CANCER (2015)
Contemporary Use of β-Blockers: Clinical Relevance of Subclassification
Luc Poirier et al.
CANADIAN JOURNAL OF CARDIOLOGY (2014)
A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response
Jason W-L Eng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Novel regulatory program for norepinephrine-induced epithelial-mesenchymal transition in gastric adenocarcinoma cell lines
Tao Shan et al.
CANCER SCIENCE (2014)
Association Between Use of β-Blockers and Prostate Cancer-Specific Survival: A Cohort Study of 3561 Prostate Cancer Patients with High-Risk or Metastatic Disease
Helene Hartvedt Grytli et al.
EUROPEAN UROLOGY (2014)
Meta-analysis of the effects of beta blocker on survival time in cancer patients
Chel Hun Choi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
β3-adrenergic receptor activity modulates melanoma cell proliferation and survival through nitric oxide signaling
Massimo Dal Monte et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
A role for cAMP-driven transactivation of EGFR in cancer aggressiveness - Therapeutic implications
Mark F. McCarty
MEDICAL HYPOTHESES (2014)
Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma
Jennifer K. Wolter et al.
ONCOTARGET (2014)
Differential β2-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines
Lucia Gargiulo et al.
ONCOTARGET (2014)
Adrenergic modulation of immune cells: an update
Franca Marino et al.
AMINO ACIDS (2013)
Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy
H. M. Wang et al.
ANNALS OF ONCOLOGY (2013)
Use of β-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study
Sigrun A. Johannesdottir et al.
BMC CANCER (2013)
Effects of tobacco constituents and psychological stress on the beta-adrenergic regulation of non-small cell lung cancer and pancreatic cancer: Implications for intervention
Hildegard M. Schuller
CANCER BIOMARKERS (2013)
Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials
Matteo Monami et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
β-blockers: a new role in cancer chemotherapy?
Archana S. Nagaraja et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG
Florian Heitz et al.
GYNECOLOGIC ONCOLOGY (2013)
Catecholamine-Induced β2-Adrenergic Receptor Activation Mediates Desensitization of Gastric Cancer Cells to Trastuzumab by Upregulating MUC4 Expression
Ming Shi et al.
JOURNAL OF IMMUNOLOGY (2013)
β-adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines
Silvia Moretti et al.
LABORATORY INVESTIGATION (2013)
Effect of Chronic Restraint Stress on Human Colorectal Carcinoma Growth in Mice
Qiang Lin et al.
PLOS ONE (2013)
β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy
Jing Tang et al.
SEMINARS IN CANCER BIOLOGY (2013)
Involvement of a2-and ß2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation
C. Perez Pinero et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Molecular Pathways: Beta-Adrenergic Signaling in Cancer
Steven W. Cole et al.
CLINICAL CANCER RESEARCH (2012)
Impact of beta blockers on epithelial ovarian cancer survival
Elena S. Diaz et al.
GYNECOLOGIC ONCOLOGY (2012)
Cooperative Regulation of Non-Small Cell Lung Carcinoma by Nicotinic and Beta-Adrenergic Receptors: A Novel Target for Intervention
Hussein A. N. Al-Wadei et al.
PLOS ONE (2012)
Immune Sculpting of Norepinephrine on MHC-I, B7-1, IDO and B7-H1 Expression and Regulation of Proliferation and Invasion in Pancreatic Carcinoma Cells
Liancai Wang et al.
PLOS ONE (2012)
Intercepting neoplastic progression in lung malignancies via the beta adrenergic (β-AR) pathway: Implications for anti-cancer drug targets
Hussein A. N. Al-Wadei et al.
PHARMACOLOGICAL RESEARCH (2012)
β-blockers: a novel class of antitumor agents
Yi Ji et al.
ONCOTARGETS AND THERAPY (2012)
Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells
Daniel G. Bernabe et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
The beta 2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells
Ming Shi et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines
Kelley S. Madden et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma
Diego Mauricio Bravo-Calderon et al.
CANCER BIOMARKERS (2011)
β-Blockers and Survival among Danish Patients with Malignant Melanoma: A Population-Based Cohort Study
Stanley Lemeshow et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
β-Adrenergic Blockers
William H. Frishman et al.
JOURNAL OF CLINICAL HYPERTENSION (2011)
Beta Blockers and Breast Cancer Mortality: A Population-Based Study
Thomas I. Barron et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Effects of adrenaline in human colon adenocarcinoma HT-29 cells
Helen P. S. Wong et al.
LIFE SCIENCES (2011)
Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis
Khoa D. Nguyen et al.
NATURE (2011)
β-arrestin2 mediates β-2 adrenergic receptor signaling inducing prostate cancer cell progression
Penghui Zhang et al.
ONCOLOGY REPORTS (2011)
Do Stress Responses Promote Leukemia Progression? An Animal Study Suggesting a Role for Epinephrine and Prostaglandin-E2 through Reduced NK Activity
Shelly Inbar et al.
PLOS ONE (2011)
Common cardiovascular medications in cancer therapeutics
Christos Vaklavas et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling
Jillian G. Baker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Ligand-directed signalling at beta-adrenoceptors
Bronwyn A. Evans et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1
Dong Zhang et al.
CANCER BIOLOGY & THERAPY (2010)
The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
Erica K. Sloan et al.
CANCER RESEARCH (2010)
Impact of stress on cancer metastasis
Myrthala Moreno-Smith et al.
FUTURE ONCOLOGY (2010)
Host Factors and Cancer Progression: Biobehavioral Signaling Pathways and Interventions
Susan K. Lutgendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Sudarshan Rajagopal et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling
Xinhua Liao et al.
ONCOLOGY REPORTS (2010)
beta-Adrenergic Receptors in Cancer: Therapeutic Implications
Mario Perez-Sayans et al.
ONCOLOGY RESEARCH (2010)
Neuroendocrine modulation of cancer progression
Guillermo N. Armaiz-Pena et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression
Eric V. Yang et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Catecholamines Regulate Tumor Angiogenesis
Debanjan Chakroborty et al.
CANCER RESEARCH (2009)
Adrenoceptors: Non Conventional Target for Breast Cancer?
I. A. Luethy et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Expression of β2-adrenergic receptor in oral squamous cell carcinoma
Zheng Jun Shang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2009)
Epidermal growth factor-induced esophageal cancer cell proliferation requires transactivation of β-adrenoceptors
Xuan Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Hormonal regulation of β2-adrenergic receptor level in prostate cancer
Hakon Ramberg et al.
PROSTATE (2008)
Effects of α-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro
Su-Gang Shen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Do stress-related psychosocial factors contribute to cancer incidence and survival?
Yoichi Chida et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Phagocyte-derived catecholamines enhance acute inflammatory injury
Michael A. Flierl et al.
NATURE (2007)
The neuroendocrine impact of chronic stress on cancer
Premal H. Thaker et al.
CELL CYCLE (2007)
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells
Eric V. Yang et al.
CANCER RESEARCH (2006)
Distinct signaling profiles of β1 and β2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy
Segolene Galandrin et al.
MOLECULAR PHARMACOLOGY (2006)
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Premal H. Thaker et al.
NATURE MEDICINE (2006)
4-(methyinitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via β-adrenoceptors
WKK Wu et al.
CANCER RESEARCH (2005)
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease -: The task force on ACE-inhibitors of the European Society of Cardiolgy
J López-Sendón et al.
EUROPEAN HEART JOURNAL (2004)
β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors
M Azzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: Differences between second messenger and reporter gene responses
JG Baker et al.
MOLECULAR PHARMACOLOGY (2003)
Depression and cancer: Mechanisms and disease progression
D Spiegel et al.
BIOLOGICAL PSYCHIATRY (2003)
Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the β2-adrenergic receptor
S Rangarajan et al.
JOURNAL OF CELL BIOLOGY (2003)
HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines
M Cosentino et al.
LIFE SCIENCES (2000)
分享论文
